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Thyroid hormones are the master regula-
tor of body metabolism and growth. They 
act at molecular level to manipulate genes 
and cellular functions to balance the basic 
metabolic rate. They bind to superfamily 
of nuclear receptors that recognize discrete 
sequences of DNA and act as transcription 
factors (Renkawitz et al., 1996).
At the cellular level, thyroid hormones act 
directly on the mitochondria. Uncoupling 
of mitochondrial energy production and 
dissipation of energy as heat are believed 
to be the main mechanism of losing energy 
and consequently body weight (Silva and 
Bianco, 2008).
The intimate collaboration of thyroid 
hormones with the sympathetic system is 
a major influence of basal body metabo-
lism and fat deposition (Silva and Bianco, 
2008). Epinephrine binds to Sympathetic 
Beta Receptor and mediates fat breakdown 
“lipolysis” and subsequently body weight 
(Dodt et al., 2003).
The search for the perfect weight loss 
formula became the holy grill mission for 
many pharmaceutical companies. Among 
many products and techniques used to 
manage body countering and weight loss is 
Mesotherapy. The controversial technique 
gained popularity in different countries, 
and recently introduced to North America. 
It was established by Michel Pistor in 1952 
(Olivero-Rivera, 2008) and its principals 
depend on injecting pharmaceutical agents 
and or nutrients into the mesodermal layer 
of the skin.
Thyroid hormones are being used in 
injectable cocktails for losing weight (Kim 
et al., 2010). The use of thyroid hormones 
in Mesotherapy is not supported by testing 
in preceding clinical trials.
The argument to use thyroid hormones 
for a transient and defiantly none permanent 
cosmetic procedure will be left to the better 
judgment of cosmetic experts. However, the 
legitimate concern from medical as well as 
from pharmaceutical point of view would be 
the dosing, effectiveness, and unwanted side 
effects associated with those hormones.
Beside the reported side effects associated 
with Mesotherapy such as infection (Correa 
et al., 2010), the use of powerful hormones by, 
in some cases, non-medical staff did not go 
without complications. For instance, a case 
of factitious thyrotoxicosis was reported after 
using cocktail containing Triiodothyroacetic 
acid (Danilovic et al., 2008).
Beside hormones, other pharmaceu-
tical agents such as Epinephrine and 
Aminophylline are also used in fat reduction 
Mesotherapy cocktails (Kim et al., 2010). In 
light of the previously mentioned factitious 
thyrotoxicosis case, systemic absorption 
seems to be an issue in supposedly localized 
technique and it could be a major contribu-
tor to side effects. Due to powerful effect 
of hormones on cells, tissue, and vascular 
system, the unorthodox use of hormones 
and more  specifically thyroid hormones in 
Mesotherapy should be strictly regulated to 
avoid serious side effects and to guarantee 
some benefits if any.
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